day 1 agenda
| Scientific Program | ||
| Day-1 (July 06, 2026) | ||
| Meeting Hall - PARIOLI-1 | ||
| 08:30-08:50 | Registrations | |
| 08:50-09:00 | Welcome Cermony | |
| Moderator:- Ximeng Han, University of Oxford, UK | ||
| Keynote Talks | ||
| Ted Rothstein, George Washington University, USA |
09:00- 09:30 | Title:- Neuroanatomic changes associated with 55 consecutive long-term post COVID-19 patients with cognitive deficits |
| Bram Palache, Flupal Consultancy, Netherlands |
09:30- 10:00 | Title:- Disparities in Seasonal Influenza Vaccination in Europe |
| Moriya Tsuji, Columbia University, USA |
10:00- 10:30 | Title:- Harnessing CD1d-restricted NKT cells to prevent respiratory viral infections in vivo |
| Group Photo & Refreshment Break (10:30-10:50) | ||
| Technical Session-I | ||
| Session Chair: Ted Rothstein, George Washington University, USA | ||
| Xiaoping Zhu, University of Maryland College Park, USA |
10:50-11:10 | Title:- An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission |
| Sofia A. Casares, Naval Medical Research Command, USA |
11:10-11:30 | Title:- Accelerating Global Health Protection: The Humanized HIS-DRAGA Mouse as a Preclinical Platform for Tropical Infectious Disease Countermeasures |
| Manish A Mahajan, Zydus Lifesciences, India |
11:30-11:50 | Title:- Adaptive Clinical Trial Designs in Lower Middle Income Countries: Role Beyond Pandemic Preparedness |
| Arlene Calvo, University of South Florida, USA |
11:50-12:10 | Title:- Follow-up of HPV Vaccine Outcomes in Panama |
| Jürgen Gailer, University of Calgaray, Canada |
12:10-12:30 | Title:- Degradation of the Vaccine Additive Thimerosal by L-Glutathione and L-Cysteine at Physiological pH |
| Rajendra Upadhya, Duke University, USA |
12:30-12:50 | Title:- Targeting Fungal Cell Wall Biology to Develop Whole-Cell Vaccines Against Cryptococcosis |
| Bella Manshion, KU Leuven, Belgium |
12:50-13:10 | Title:- Combination therapy of inorganic nanocparticles with Anti-PD1 reduces tumor growth and acts as targeted selective anti-tumor therapy |
| Lunch Break @ Restaurant (13:10-14:00) | ||
| Technical Session-II | ||
| Session Chairs: Arlene Calvo, University of South Florida, USA & Moriya Tsuji, Columbia University, USA | ||
| Rene Traksel, Maxima Medical Center, Netherlands |
14:00-14:20 | Title:- Oral iodine in COVID-19 patients: effects on clinical outcomes and antiviral immune responses |
| Adam Frederik Sander, University of Copenhagen, Denmark |
14:20-14:40 | Title:- Combining mRNA Speed with cVLP immunogenicity - A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles |
| Albert Jonathan Auguste, Virginia Tech, USA |
14:40-15:00 | Title:- Exploring the immunogenicity and efficacy of an insect virus-based vaccine against Zika virus and Spondweni virus |
| Ademola O. Olaniran, University of KwaZulu-Natal, South Africa |
15:00-15:20 | Title:- Rotaviruses in treated wastewater effluent and receiving aquatic milieu: Prevalence, Genetic characterization and Infectivity |
| Mya Myat Ngwe Tun, Nagasaki University, Japan |
15:20-15:40 | Title:- : A Multicounty assessment of Chikungunya Virus Infection in Asia Using Molecular and Serological Approaches |
| Maroua Kammoun, CER groupe, Belgium |
15:40-16:00 | Title:- : BLI as a rapid and label-free technology for characterizing biomolecular interactions in immunology |
| Refreshment Break (16:00-16:20) | ||
| Sara Al Dahir & Alaa Khalil, Xavier University of Louisiana, USA |
16:20-16:40 | Title:- : The Impact of Coronavirus Pandemic Shutdowns on Immunization Completion in Hadeetha, Anbar, Iraq: A Case-Study of Vaccine Completion in a Recovering Healthcare System |
| Raymond Kaempfer, Hebrew University of Jerusalem, Israel |
16:40-17:00 | Title:-Positive Regulation of Splicing of Cellular and Viral mRNA by Intragenic RNA Elements That Activate the Stress Kinase PKR, an Antiviral Mechanism |
| Beatriz López-Cauce, Worg Pharmaceuticals, Spain |
17:00-17:20 | Title:- Real World Safety and Effectiveness of High Dose Subcutaneous Immunotherapy with Glutaraldehyde Polymerized Allergen Extracts in Respiratory Allergy |
| Laura Ortega Martín, Worg Pharmaceuticals, Spain |
17:20-17:40 | Title:- Molecular Sensitization Patterns to Dust Mite Allergens in a Region of Galicia: A Serodominance Study in Lugo |
| Panel Discussions | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to: ryan_cooper@vaccine-congress.org | ||
day 2 agenda
| Day-2 (July 07, 2026) | ||
| Meeting Hall - PARIOLI 1 | ||
| 09:20-09:30 | Welcome Remarks by Moderator | |
| Moderator:- Mya Myat Ngwe Tun, Nagasaki University, Japan | ||
| Keynote Talks | ||
| Airi Poder, Clinical Research OU, Estonia |
09:30-10:00 | Title:- Recruitment Strategies for Vaccine Trials in Areas of Low Population Density |
| Kai-Michael Toellner, Babraham Institue, UK |
10:00-10:30 | Title:- Mastering Immunity: Antibody Feedback as a Driver of Germinal Centre Fate and Vaccine Responses |
| Technical Session-III | ||
| Session Chairs: Kai-Michael, Toellner Babraham Institue, UK | ||
| Camilla Foged, University of Copenhagen, Denmark |
10:30-10:50 | Title:- Design of messenger RNA vaccines based on lipid-polymer hybrid nanoparticles |
| Sara Landeras, University CEU, Spain |
10:50-11:10 | Title:- Antigenic landscape and structural stabilization of the SARS-CoV-2 Nucleocapsid protein |
| Refreshment Break (11:10-11:30) | ||
| Andrea Malaspina, University College London, UK |
11:30-11:50 | Title:- Neurofilament and Dipeptide Repeats Autoantibodies and Loss of Immune Tolerance in Amyotrophic Lateral Sclerosis |
| Roberto Ademo, GlaxoSmithkile, Italy |
11:50-12:10 | Title:- Towards a polysaccharide-based Group B Streptococcus vaccinefor Global Health |
| Ying Peng, Zhengzhou University, China |
12:10-12:30 | Title:- A cDC1 targeting, plug-and-play custom nanoparticle vaccine triggers effective cancer immunity |
| Gertrude Nakigozi, SDSU, USA |
12:30-12:50 | Title:- Preparing for Expanded Maternal Immunization: Healthcare Provider Perspectives on Barriers to Vaccine Uptake in Uganda |
| Ximeng Han, University of Oxford, UK |
12:50-13:10 | Title:- Preclinical Development of an Enhanced-Immunogenicity Malaria Transmission-Blocking Vaccine |
| Lunch Break @ Restaurant (13:10-14:00) | ||
| Technical Session- IV (14:00-14:40) - Poster Viewing | ||
| Technical Session- V | ||
| Session Chair: Camilla Foged, University of Copenhagen, Denmark | ||
| Clint McDaniel, UMass Chan, USA |
14:40- 15:00 | Title:- Cryo-electron tomography reveals virion-associated influenza hemagglutinin clusters upon receptor binding |
| Stine Søgaard Normann, University of Southern Denmark, Copenhagen |
15:00- 15:20 | Title:- Prenatal and childhood PFAS exposure and vaccine?induced immunity at 15 years of age in a Faroe mother?child cohort |
| Sam Pallerla, IAVI, USA |
15:20-15:40 | Title:- Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoparticles (SMNP) |
| Mouhamed Kane, Institut Pasteur de Daka, Senegal |
15:40-16:00 | Title:- Evaluating Myxovirus Resistance Protein A-Based Rapid Testing Combined with Pathogen Sequencing for Arboviral and Incidental Viral Infection Surveillance in Senegal |
| Daniel Knott, UKHSA, UK |
16:00-16:20 | Title:- From development to deployment: transferring SARS CoV 2 neutralisation assays across a global laboratory network |
| Antonio Acosta-Hoyos, Universidad Simón Bolívar, Columbia |
16:20-16:40 | Title:- Point-of-care dengue screening and viremia stratification by raman spectroscopy of serum liquid biopsies |
| Refreshment Break (16:40-17:00) | ||
| Panel Discussions | ||
| If any one interested to attend the conference or to book your speaker slot, please send an email to: ryan_cooper@vaccine-congress.org | ||
posters agenda
| Poster Presentations | ||
| Day-2 (July 07, 2026) | ||
| Technical Session- IV (14:00-15:00) - Poster Viewing | ||
| Gulgul Kairanbayeva, Asfendiyarov Kazakh National Medical University, Kazakhstan |
P-1 | Title:- Artificial Intelligence-Assisted PASI Scoring in Experimental Psoriasis: comparison with Classical Method |
| Marina Balabekova, Asfendiyarov Kazakh National Medical University, Kazakhstan |
P-2 | Title:- Phosphorodiamidate Morpholino Oligomers Demonstrate Pronounced Anti-Inflammatory Activity in Experimental Psoriasis |
| Diana Luisa Campos Ferreira Ramos, University of Porto, Portugal |
P-3 | Title:- Identification of mosquito antigens using reverse vaccinology to design a vaccine candidate against multiple flaviviruses |
| Elchin Huseynov, Azerbaijan Medical University, Azerbaijan |
P-4 | Title:- The Features Of Acute Brucellosis In Azerbaijan Republic |
| Gertrude Nakigozi, SDSU, USA |
P-5 | Title:- Complacency and convenience remain linked despite high vaccine confidence: attitudes among pregnant individuals, those planning pregnancy, and partners in Uganda |
| Anderson Pereira Soares, University of Campinas, Brazil |
P-6 | Title:- B-cell epitope mapping of Orthoflavivirus zikaense in mother-newborn immune interaction reveals postnatal immune signatures |
| Panel Discussions | ||
| NOTE: This is Tentative program and subject to change | ||
| If any one interested to attend the conference or to book your poster slot, please send an email to: foodscience@innovinc.org | ||
posters agenda
| Virtual Scientific Program | ||
| Day-2 (July 07, 2026) (CEST Time Zone) | ||
| Anju Kaushal, University of Auckland, New Zealand |
10:00-10:20 | Title:- mRNA vaccination Strategies- A perspective |
| Louise C Rowntree, University of Melbourne, Australia |
10:20-10:40 | Title:- Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity |
| Dong Zhang, Anhui Medical University, China |
10:40-11:00 | Title:- Whole Cancer Cell Vaccine Protects Ovarian Functions in Tumor bearing Mice through Downregulating CXCL10 |
| Nan Wu, Chinese Academy of Sciences, China |
11:00-11:20 | Title:- Functional Divergence of Duplicated Cytokine Signaling Regulators Defines Stage-Specific Immunometabolic Control of Metaflammation |
| Anahita Razaghian, Tehran University of Medical Sciences, Iran |
11:20-11:40 | Title:- Heterogeneous Disease Courses in Adenosine Deaminase 2 Deficiency (DADA2): A Report of Two Cases |
| Moussa Moise, Institut Pasteur de Dakar, Senegal |
11:40-12:00 | Title:- Genomic surveillance of Rift Valley fever virus lineage H during the 2025 Senegal outbreak: implications for vaccine readiness and epidemic preparedness |
| Claudia Fowler-Williams, Frimley Park Hospital NHS Trust, UK |
12:00-12:20 | Title:- A facial lesion caused by Mycobacterium gordonae infection |
| Margaret Efua Sackey, University of Limerick, Ireland |
12:20-12:40 | Title:- Strategies used by healthcare professionals to increase the human papillomavirus vaccine uptake among adolescents in Ireland: A qualitative study |
| Bernd Schollmeier, Helvetic consulting, Switzerland |
12:40-13:00 | Title:- Mind the gap: De-risking vaccine development for new market access requirements |
| Karen Sherwood, Greenwich School, USA |
13:00-13:20 | Title:- Beyond HLA: An adaptive nanopore sequencing assay for simultaneous HLA and blood group profiling in transplantation |
| Michal Schwartz, Weizmann Institute of Science, Israel |
13:20-13:40 | Title:- Unleashing the immmune system to fight neurodegeneration in the brain |
| Tyler Malkin, Greenwich School, USA |
13:40-14:00 | Title:- The Safety of Aluminum as an Adjuvant in Vaccines: A Review and Analysis |
| Marjan Gharagozloo, Johns Hopkins University School of Medicine, USA |
14:00-14:20 | Title:- Targeting Innate Immune Signaling to Promote Neuroprotection in Progressive Multiple Sclerosis |
| George W. Burke III, University of Miami, Miami Transplant Institute, USA |
14:20-14:40 | Title:- Retransplantation of the pancreas after the development of recurrent autoimmunity following a previous pancreas transplant |
| Rong Fang, University of Texas Medical Branch, USA |
14:40-15:00 | Title:- Vaccination-induced neutralizing antibodies against tick-borne intracellular bacteria |
| Quo Huo, University of Central Florida, USA |
15:00-15:20 | Title:- D2Dx Immunity Test - A Rapid Blood Test to Measure the General Humoral Immune Response Reflecting Th1/Th2 Immunity Balance in Humans Upon Infection or Vaccination |
| David Saunders, Lumen Bioscience, USA |
15:20-15:40 | Title:- Towards a low cost, cold chain-independent and needle-free seasonal booster for sustaining malaria immunity |
| Anastasia Nijnik, McGill University, Canada |
15:40-16:00 | Title:- Regulation of B lymphocyte development and antibody-mediated immunity by histone deubiquitinating enzymes |
| Thomas P Monath, Quigley Biopharma, USA |
16:00-16:20 | Title:- PHV02 Live, attenuated recombinant VSV vaccine against Nipah Virus: Clinical trial update |
| Eréndira Itzel García Islas, Universidad Nacional Autónoma de México, Mexico |
16:20-16:40 | Title:- Machine Learning to the Analysis of Lethality and Clinical Progression of SARS-CoV-2 Infection in Mexico City Metro Workers |
| Michael P. Kladde, University of Florida, United States |
16:40-17:00 | Title:- A murine model of sepsis induces age- and sex-specific chromatin remodeling in myeloid derived suppressor cells |
| Panel Discussions | ||
| If any one interested to attend the conference or to book your virtual speaker slot, please send an email to: ryan_cooper@vaccine-congress.org | ||